Evidence map›Paper›PMID 35037135›Full record

ArticleActa diabetologica2022

Predisposition of SOD1, GPX1, CAT genetic variants and their haplotypes in cataractogenesis of type 2 diabetes mellitus in Pakistan.

Sanober Kafeel, Zehra Hashim, Asher Fawwad, Syeda Nuzhat Nawab

Abstract read
PubMed Publisher
In one paragraph

Article in Acta diabetologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sanober KafeelThe Karachi Institute of Biotechnology and Genetic Engineering (KIBGE), University of Karachi, Karachi, 75270, Pakistan.ORCID https://orcid.org/0000-0003-1282-6347
Zehra HashimDr. Zafar H. Zaidi Center for Proteomics, University of Karachi, Karachi, 75270, Pakistan.ORCID https://orcid.org/0000-0001-6750-093X
Asher FawwadBaqai Institute of Diabetology and Endocrinology (BIDE), Karachi, 74600, Pakistan.ORCID https://orcid.org/0000-0002-2094-9497
Syeda Nuzhat NawabThe Karachi Institute of Biotechnology and Genetic Engineering (KIBGE), University of Karachi, Karachi, 75270, Pakistan. nuzhat.nawab@kibge.edu.pk.ORCID http://orcid.org/0000-0002-4828-3287
University of Karachi · PKBaqai Medical University · PK

Funding

Higher Education Commision, Pakistan 6575/Sindh/NRPU/R&D/HEC/2016
6 · The paper itself

Abstract

aimsCataract formation is accelerated by hyperglycemia due to the excessive production of oxidative stress. This study aimed to examine the underlaying role of glutathione peroxidase 1 (GPX1) rs1800668, catalase (CAT) rs1001179 and superoxide dismutase 1 (SOD1) 50 bp Indel promotor region variants in the pathogenesis of cataract in patients with diabetes.

methodsA population-based case-control study of n=680 individuals was conducted which comprised of four respective groups: type 2 diabetes mellitus, diabetic cataract, senile cataract patients and controls. Screening of genotypes was performed by allele-specific (AS) and conventional polymerase chain reaction (PCR). Statistical testing was carried out using SPSS© 20.0, MedCal© and SNPStats© software's. Bioinformatics analysis of linkage disequilibrium was done by HaploView© software 7.0.

resultsGPX1 (rs1800668) showed significant association with higher susceptibility of opacification in type 2 diabetes mellitus (χ

conclusionsGPX1 (rs1800668) variant may serve as an antioxidant biomarker for the assessment of risk for cataract in type 2 diabetes mellitus. GPX1 enzyme owed an antioxidant activity which can reduce the oxidative stress and hence could develop resistance in cataractogenesis. The findings could be beneficial as a potential target to the future pharmacogenomic studies of cataract prevention and eradication in diabetes mellitus.

Indexed as

CataractDiabetes ComplicationsDiabetes Mellitus, Type 2AntioxidantsCase-Control StudiesCatalaseGenetic Predisposition to DiseaseGlutathione PeroxidaseGlutathione Peroxidase GPX1HaplotypesHumansOxidative StressPakistanPolymorphism, Single NucleotideSuperoxide DismutaseSuperoxide Dismutase-1AntioxidantsCatalaseGlutathione PeroxidaseGlutathione Peroxidase GPX1GPX1 protein, humanSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Antioxidant enzymesCataractOxidative stressPromotorSenileType 2 Diabetes mellitus

Identifiers

PMID35037135
OpenAlexW4206159055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.